Approximate number of patients recruited in phase II clinical trials of a drug are?
## **Core Concept**
Phase II clinical trials are a critical stage in the development of a new drug, primarily aimed at assessing its efficacy and side effects. These trials involve a larger group of patients than phase I trials but are still smaller than the groups in phase III trials. The primary goal is to determine the efficacy of the drug and to further evaluate its safety.
## **Why the Correct Answer is Right**
The correct answer, **20-100 patients**, reflects the typical range for phase II clinical trials. At this stage, the drug is administered to a larger population to gather preliminary data on whether the drug works in people who have a certain disease or condition. This phase helps in identifying the optimal dose and assessing the drug's efficacy. The relatively small number of patients allows for detailed monitoring and provides valuable insights into the drug's effects without exposing too many people to potential risks.
## **Why Each Wrong Option is Incorrect**
- **Option A (Less than 20):** This number is too small for phase II trials, which typically involve more patients than phase I to get meaningful efficacy data. Phase I trials usually involve a smaller number of participants (20 or fewer).
- **Option C (100-500):** This range is more suitable for phase III clinical trials, which involve larger groups of patients to confirm efficacy, monitor side effects, compare the drug to commonly used treatments, and collect information that will allow the experimental drug to be used safely.
- **Option D (More than 1000):** This is definitely too large for phase II trials and more representative of phase III or even post-marketing surveillance studies.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that phase II clinical trials are crucial for determining the **therapeutic dose** and **efficacy** of a drug. These trials often involve **randomization** and may include a **control group** to compare outcomes. Understanding the purpose and typical patient numbers for each phase of clinical trials can help in better grasping the drug development process.
## **Correct Answer:** B. 20-100.